Alexander McGirr1, Michael D Cusimano. 1. Injury Prevention Research, St-Michael's Hospital, University of Toronto, Toronto, ON, Canada. alexander.mcgirr@alum.utoronto.ca
Abstract
OBJECTIVE: Idiopathic normal pressure hydrocephalus (iNPH) is considered sporadic, yet familial cases involving single pedigrees are being increasingly recognized. As current evidence does not extend beyond isolated pedigrees, we aimed to determine the putative heritability of iNPH by examining the prevalence of the iNPH triad among the family members of iNPH probands. METHOD: We present a case-control family study of the iNPH symptom triad among the relatives of iNPH patients (n=20) identified from a cohort of patients undergoing CSF diversion and matched comparison subjects (n=21). A total of 291 first-degree relatives from 41 families were characterized using semi-structured family history interviews. Independent from the family study, we present a novel well-characterized familial case of iNPH. RESULTS: ≥ 2 insidious, progressive and idiopathic iNPH symptoms were identified among first degree relatives in 6 iNPH pedigrees (2 multiply affected) and 1 control pedigree, with an incidence of 7.1% among iNPH relatives and 0.7% among control relatives (OR=11.53). Gait disturbance and memory impairment began at a younger age among the relatives of iNPH probands. Independent of our family study, we present a novel case report of a large iNPH pedigree with multiple affected relatives. INTERPRETATION: Our family study and novel familial case suggest familial aggregation of iNPH. A larger family study with full characterization of affected and unaffected relatives is warranted. Confirmation of heritability may allow identification of individuals at high-risk for iNPH, early intervention, and improved aetiological elucidation.
OBJECTIVE: Idiopathic normal pressure hydrocephalus (iNPH) is considered sporadic, yet familial cases involving single pedigrees are being increasingly recognized. As current evidence does not extend beyond isolated pedigrees, we aimed to determine the putative heritability of iNPH by examining the prevalence of the iNPH triad among the family members of iNPH probands. METHOD: We present a case-control family study of the iNPH symptom triad among the relatives of iNPH patients (n=20) identified from a cohort of patients undergoing CSF diversion and matched comparison subjects (n=21). A total of 291 first-degree relatives from 41 families were characterized using semi-structured family history interviews. Independent from the family study, we present a novel well-characterized familial case of iNPH. RESULTS: ≥ 2 insidious, progressive and idiopathic iNPH symptoms were identified among first degree relatives in 6 iNPH pedigrees (2 multiply affected) and 1 control pedigree, with an incidence of 7.1% among iNPH relatives and 0.7% among control relatives (OR=11.53). Gait disturbance and memory impairment began at a younger age among the relatives of iNPH probands. Independent of our family study, we present a novel case report of a large iNPH pedigree with multiple affected relatives. INTERPRETATION: Our family study and novel familial case suggest familial aggregation of iNPH. A larger family study with full characterization of affected and unaffected relatives is warranted. Confirmation of heritability may allow identification of individuals at high-risk for iNPH, early intervention, and improved aetiological elucidation.
Authors: Okko T Pyykkö; Miikka Lumela; Jaana Rummukainen; Ossi Nerg; Toni T Seppälä; Sanna-Kaisa Herukka; Anne M Koivisto; Irina Alafuzoff; Lakshman Puli; Sakari Savolainen; Hilkka Soininen; Juha E Jääskeläinen; Mikko Hiltunen; Henrik Zetterberg; Ville Leinonen Journal: PLoS One Date: 2014-03-17 Impact factor: 3.240
Authors: Ville E Korhonen; Seppo Helisalmi; Aleksi Jokinen; Ilari Jokinen; Juha-Matti Lehtola; Minna Oinas; Kimmo Lönnrot; Cecilia Avellan; Anna Kotkansalo; Janek Frantzen; Jaakko Rinne; Antti Ronkainen; Mikko Kauppinen; Antti Junkkari; Mikko Hiltunen; Hilkka Soininen; Mitja Kurki; Juha E Jääskeläinen; Anne M Koivisto; Hidenori Sato; Takeo Kato; Anne M Remes; Per Kristian Eide; Ville Leinonen Journal: Neurol Genet Date: 2018-12-03
Authors: Hong Wei Yang; Semin Lee; Dejun Yang; Huijun Dai; Yan Zhang; Lei Han; Sijun Zhao; Shuo Zhang; Yan Ma; Marciana F Johnson; Anna K Rattray; Tatyana A Johnson; George Wang; Shaokuan Zheng; Rona S Carroll; Peter J Park; Mark D Johnson Journal: EMBO Mol Med Date: 2021-01-18 Impact factor: 12.137
Authors: Joel Räsänen; Joel Huovinen; Ville E Korhonen; Antti Junkkari; Sami Kastinen; Simo Komulainen; Minna Oinas; Cecilia Avellan; Janek Frantzen; Jaakko Rinne; Antti Ronkainen; Mikko Kauppinen; Kimmo Lönnrot; Markus Perola; Anne M Koivisto; Anne M Remes; Hilkka Soininen; Mikko Hiltunen; Seppo Helisalmi; Mitja I Kurki; Juha E Jääskeläinen; Ville Leinonen Journal: Fluids Barriers CNS Date: 2020-09-15